Raul Gainetdinov, Ph.D. - Publications

Affiliations: 
Italian Institute of Technology, Genoa, United States 

112/354 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Traktirov DS, Nazarov IR, Artemova VS, Gainetdinov RR, Pestereva NS, Karpenko MN. Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter. Biomedicines. 11. PMID 38001881 DOI: 10.3390/biomedicines11112881  0.317
2023 Savchenko A, Targa G, Fesenko Z, Leo D, Gainetdinov RR, Sukhanov I. Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience. Biomolecules. 13. PMID 37238676 DOI: 10.3390/biom13050806  0.35
2023 Kozlova AA, Rubets E, Vareltzoglou MR, Jarzebska N, Ragavan VN, Chen Y, Martens-Lobenhoffer J, Bode-Böger SM, Gainetdinov RR, Rodionov RN, Bernhardt N. Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 36792833 DOI: 10.1007/s00702-023-02597-7  0.31
2023 Volnova A, Kurzina N, Belskaya A, Gromova A, Pelevin A, Ptukha M, Fesenko Z, Ignashchenkova A, Gainetdinov RR. Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine. Biomedicines. 11. PMID 36672730 DOI: 10.3390/biomedicines11010222  0.329
2022 Nemets VV, Deal AL, Sobolev VE, Grinevich VP, Gainetdinov RR, Budygin EA. Short-Term Consequences of Single Social Defeat on Accumbal Dopamine and Behaviors in Rats. Biomolecules. 13. PMID 36671420 DOI: 10.3390/biom13010035  0.324
2022 Sukhanov I, Dorotenko A, Fesenko Z, Savchenko A, Efimova EV, Mor MS, Belozertseva IV, Sotnikova TD, Gainetdinov RR. Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease Therapy. Biomolecules. 13. PMID 36671394 DOI: 10.3390/biom13010009  0.36
2022 Zhukov IS, Karpova IV, Krotova NA, Tissen IY, Demin KA, Shabanov PD, Budygin EA, Kalueff AV, Gainetdinov RR. Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1). International Journal of Molecular Sciences. 23. PMID 36430544 DOI: 10.3390/ijms232214066  0.308
2022 Efimova EV, Kuvarzin SR, Mor MS, Katolikova NV, Shemiakova TS, Razenkova V, Ptukha M, Kozlova AA, Murtazina RZ, Smirnova D, Veshchitskii AA, Merkulyeva NS, Volnova AB, Musienko PE, Korzhevskii DE, ... ... Gainetdinov RR, et al. Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis. Frontiers in Behavioral Neuroscience. 16: 847410. PMID 35431833 DOI: 10.3389/fnbeh.2022.847410  0.347
2021 Sørensen G, Rickhag M, Leo D, Lycas MD, Ridderstrøm PH, Weikop P, Lilja JH, Rifes P, Herborg F, Woldbye D, Wörtwein G, Gainetdinov RR, Fink-Jensen A, Gether U. Disruption of the PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation. The Journal of Biological Chemistry. 101361. PMID 34756883 DOI: 10.1016/j.jbc.2021.101361  0.363
2021 Zhukov IS, Kubarskaya LG, Karpova IV, Vaganova AN, Karpenko MN, Gainetdinov RR. Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice. International Journal of Molecular Sciences. 22. PMID 34298937 DOI: 10.3390/ijms22147307  0.306
2020 Sotnikova TD, Efimova EV, Gainetdinov RR. Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor. International Journal of Molecular Sciences. 21. PMID 33153031 DOI: 10.3390/ijms21218216  0.414
2020 Efimova EV, Kozlova AA, Razenkova V, Katolikova NV, Antonova KA, Sotnikova TD, Merkulyeva NS, Veshchitskii AS, Kalinina DS, Korzhevskii DE, Musienko PE, Kanov EV, Gainetdinov RR. Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice. Neuropharmacology. 182: 108373. PMID 33132188 DOI: 10.1016/j.neuropharm.2020.108373  0.377
2020 Kurzina NP, Aristova IY, Volnova AB, Gainetdinov RR. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Behavioural Brain Research. 390: 112642. PMID 32428629 DOI: 10.1016/j.bbr.2020.112642  0.307
2019 Lopachev A, Volnova A, Evdokimenko A, Abaimov D, Timoshina Y, Kazanskaya R, Lopacheva O, Deal A, Budygin E, Fedorova T, Gainetdinov R. Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation. Scientific Reports. 9: 15627. PMID 31666560 DOI: 10.1038/S41598-019-52058-Z  0.423
2019 Belov DR, Efimova EV, Fesenko ZS, Antonova KA, Kolodyazhny SF, Lakstygal AM, Gainetdinov RR. Putative Trace-Amine Associated Receptor 5 (TAAR5) Agonist α-NETA Increases Electrocorticogram Gamma-Rhythm in Freely Moving Rats. Cellular and Molecular Neurobiology. 40: 203-213. PMID 31385135 DOI: 10.1007/s10571-019-00716-1  0.32
2019 Efimova E, Katolikova N, Kozlova A, Antonova K, Murtazina R, Merkulyeva N, Veshchitskii A, Musienko P, Суханов ИМ, Espinoza S, Gainetdinov R. The role of trace amine associated receptor 5 (TAAR5) in mouse behavior and brain neurochemistry European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.09.177  0.332
2019 Efimova E, Gerasimov A, Sukhanov I, Korenkova O, Antonova K, Ptuha M, Volnova A, Gainetdinov R. Identification of the agonist of trace amine-associated receptor 5 (TAAR5) and its action on brain physiology and neurochemistry European Neuropsychopharmacology. 29: S571-S572. DOI: 10.1016/J.Euroneuro.2018.11.848  0.333
2019 Kurzina N, Volnova A, Aristova I, Gainetdinov R. Effects of dopamine level on object recognition and formation of cognitive maps in rats European Neuropsychopharmacology. 29: S139-S140. DOI: 10.1016/J.Euroneuro.2018.11.253  0.337
2018 Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A. Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953. PMID 30233365 DOI: 10.3389/Fphar.2018.00953  0.305
2018 Espinoza S, Leo D, Sotnikova TD, Shahid M, Kääriäinen TM, Gainetdinov RR. Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397. Frontiers in Pharmacology. 9: 645. PMID 29977204 DOI: 10.3389/fphar.2018.00645  0.343
2018 Meshalkina DA, Kysil EV, Antonova KA, Demin KA, Kolesnikova TO, Khatsko SL, Gainetdinov RR, Alekseeva PA, Kalueff AV. The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry. Neurochemical Research. PMID 29740748 DOI: 10.1007/s11064-018-2536-5  0.324
2018 Cinque S, Zoratto F, Poleggi A, Leo D, Cerniglia L, Cimino S, Tambelli R, Alleva E, Gainetdinov RR, Laviola G, Adriani W. Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia. Frontiers in Psychiatry. 9: 43. PMID 29520239 DOI: 10.3389/Fpsyt.2018.00043  0.332
2018 Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EE, Niello M, Espinoza S, ... ... Gainetdinov RR, et al. PRONOUNCED HYPERACTIVITY, COGNITIVE DYSFUNCTIONS AND BDNF DYSREGULATION IN DOPAMINE TRANSPORTER KNOCKOUT RATS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29348190 DOI: 10.1523/JNEUROSCI.1931-17.2018  0.349
2016 Mikhailova MA, Bass CE, Grinevich VP, Chappell AM, Deal AL, Bonin KD, Weiner JL, Gainetdinov RR, Budygin EA. Optogenetically-induced tonic dopamine release from VTA-nucleus accumbens projections inhibits reward consummatory behaviors. Neuroscience. PMID 27421228 DOI: 10.1016/J.Neuroscience.2016.07.006  0.335
2016 Fox ME, Mikhailova MA, Bass CE, Takmakov P, Gainetdinov RR, Budygin EA, Wightman RM. Cross-hemispheric dopamine projections have functional significance. Proceedings of the National Academy of Sciences of the United States of America. PMID 27298371 DOI: 10.1073/Pnas.1603629113  0.334
2016 Efimova EV, Gainetdinov RR, Budygin EA, Sotnikova TD. Dopamine transporter mutant animals: a translational perspective. Journal of Neurogenetics. 30: 5-15. PMID 27276191 DOI: 10.3109/01677063.2016.1144751  0.364
2016 Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacological Research. PMID 27178731 DOI: 10.1016/J.Phrs.2016.05.010  0.342
2016 Efimova E, Leo D, Sukhanov I, Illiano P, Mus L, Espinoza S, Sotnikova T, Hoener M, Gainetdinov R. Dopamine transporter knockout rats as a novel model of dopamine associated disorders European Neuropsychopharmacology. 26: S274. DOI: 10.1016/S0924-977X(16)31160-9  0.337
2015 Lam VM, Espinoza S, Gerasimov AS, Gainetdinov RR, Salahpour A. In-vivo pharmacology of Trace-Amine Associated Receptor 1. European Journal of Pharmacology. PMID 26093041 DOI: 10.1016/J.Ejphar.2015.06.026  0.361
2015 Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology. 93: 308-13. PMID 25721394 DOI: 10.1016/j.neuropharm.2015.02.010  0.368
2015 Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. British Journal of Pharmacology. 172: 1-23. PMID 25671228 DOI: 10.1111/bph.12906  0.365
2015 Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, et al. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiology of Disease. 74: 66-75. PMID 25447236 DOI: 10.1016/J.Nbd.2014.10.016  0.361
2014 Sukhanov I, Espinoza S, Yakovlev DS, Hoener MC, Sotnikova TD, Gainetdinov RR. TAAR1-dependent effects of apomorphine in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1683-93. PMID 24925023 DOI: 10.1017/S1461145714000509  0.355
2014 Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, ... ... Gainetdinov RR, et al. In vivo amphetamine action is contingent on αCaMKII. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2681-93. PMID 24871545 DOI: 10.1038/Npp.2014.124  0.357
2014 Daigle TL, Ferris MJ, Gainetdinov RR, Sotnikova TD, Urs NM, Jones SR, Caron MG. Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2450-62. PMID 24776686 DOI: 10.1038/Npp.2014.97  0.395
2014 Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. The European Journal of Neuroscience. 40: 2255-63. PMID 24754704 DOI: 10.1111/Ejn.12594  0.376
2014 Cagniard B, Sotnikova TD, Gainetdinov RR, Zhuang X. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. Journal of Neurogenetics. 28: 112-21. PMID 24673634 DOI: 10.3109/01677063.2014.908191  0.343
2014 Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology. 81: 283-91. PMID 24565640 DOI: 10.1016/j.neuropharm.2014.02.007  0.383
2014 Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biological Psychiatry. 75: 479-86. PMID 23305992 DOI: 10.1016/J.Biopsych.2012.11.024  0.306
2013 Medvedev IO, Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A. D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18125-33. PMID 24227722 DOI: 10.1523/Jneurosci.2382-13.2013  0.365
2012 Managò F, Espinoza S, Salahpour A, Sotnikova TD, Caron MG, Premont RT, Gainetdinov RR. The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment. Scientific Reports. 2: 301. PMID 22393477 DOI: 10.1038/Srep00301  0.331
2012 Meck WH, Cheng RK, MacDonald CJ, Gainetdinov RR, Caron MG, Cevik MÖ. Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice. Neuropharmacology. 62: 1221-9. PMID 21296093 DOI: 10.1016/J.Neuropharm.2011.01.042  0.495
2011 Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience. 4: 38. PMID 22065948 DOI: 10.3389/fnmol.2011.00038  0.346
2011 Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Molecular Pharmacology. 80: 416-25. PMID 21670104 DOI: 10.1124/Mol.111.073304  0.368
2011 Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, et al. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proceedings of the National Academy of Sciences of the United States of America. 108: 8485-90. PMID 21525407 DOI: 10.1073/Pnas.1103029108  0.373
2011 Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews. 63: 182-217. PMID 21303898 DOI: 10.1124/pr.110.002642  0.346
2010 Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. The dopamine metabolite 3-methoxytyramine is a neuromodulator. Plos One. 5: e13452. PMID 20976142 DOI: 10.1371/Journal.Pone.0013452  0.392
2009 Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cellular Signalling. 21: 87-94. PMID 18929645 DOI: 10.1016/J.Cellsig.2008.09.011  0.382
2008 Sotnikova TD, Zorina OI, Ghisi V, Caron MG, Gainetdinov RR. Trace amine associated receptor 1 and movement control. Parkinsonism & Related Disorders. 14: S99-102. PMID 18585080 DOI: 10.1016/j.parkreldis.2008.04.006  0.351
2008 Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K, Sesack SR, Wightman RM, Gainetdinov RR, Caron MG. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 105: 4405-10. PMID 18347339 DOI: 10.1073/Pnas.0707646105  0.381
2008 Gainetdinov RR. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology. 377: 301-13. PMID 18057916 DOI: 10.1007/s00210-007-0216-0  0.393
2007 Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacological Sciences. 28: 166-72. PMID 17349698 DOI: 10.1016/j.tips.2007.02.006  0.313
2007 Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 881-5. PMID 17251429 DOI: 10.1523/Jneurosci.5074-06.2007  0.32
2007 Costa RM, Gutierrez R, de Araujo IE, Coelho MR, Kloth AD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. Dopamine levels modulate the updating of tastant values. Genes, Brain, and Behavior. 6: 314-20. PMID 16848782 DOI: 10.1111/J.1601-183X.2006.00257.X  0.347
2006 Caron MG, Gainetdinov RR. Dopamine: from pharmacology to molecular biology and back. Wiener Klinische Wochenschrift. 118: 565-8. PMID 17136328 DOI: 10.1007/s00508-006-0735-6  0.311
2006 Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2541-3. PMID 17065224 DOI: 10.1096/fj.06-6533fje  0.384
2006 Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, Nicolelis MA. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron. 52: 359-69. PMID 17046697 DOI: 10.1016/j.neuron.2006.07.030  0.309
2006 Sotnikova TD, Caron MG, Gainetdinov RR. DDD mice, a novel acute mouse model of Parkinson's disease. Neurology. 67: S12-7. PMID 17030735  0.339
2006 Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. The Journal of Biological Chemistry. 281: 32072-80. PMID 16954211 DOI: 10.1074/jbc.M606062200  0.355
2006 Sasaki A, Sotnikova TD, Gainetdinov RR, Jarvis ED. Social context-dependent singing-regulated dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9010-4. PMID 16943558 DOI: 10.1523/JNEUROSCI.1335-06.2006  0.322
2006 Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. Cns & Neurological Disorders Drug Targets. 5: 45-56. PMID 16613553 DOI: 10.2174/187152706784111579  0.34
2005 Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 122: 261-73. PMID 16051150 DOI: 10.1016/j.cell.2005.05.012  0.323
2005 Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. Plos Biology. 3: e271. PMID 16050778 DOI: 10.1371/Journal.Pbio.0030271  0.397
2004 Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proceedings of the National Academy of Sciences of the United States of America. 101: 7781-6. PMID 15136721 DOI: 10.1073/pnas.0401418101  0.383
2004 Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America. 101: 5099-104. PMID 15044694 DOI: 10.1073/Pnas.0307921101  0.332
2004 Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology. 173: 310-7. PMID 14747902 DOI: 10.1007/S00213-003-1765-7  0.322
2004 Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 221-8. PMID 14603268 DOI: 10.1038/Sj.Npp.1300343  0.33
2003 Cyr M, Beaulieu JM, Laakso A, Sotnikova TD, Yao WD, Bohn LM, Gainetdinov RR, Caron MG. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 100: 11035-40. PMID 12958210 DOI: 10.1073/Pnas.1831768100  0.341
2003 Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 38: 291-303. PMID 12718862 DOI: 10.1016/S0896-6273(03)00192-2  0.369
2002 Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR, Caron MG, Wightman RM. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience. 112: 39-49. PMID 12044470 DOI: 10.1016/S0306-4522(02)00067-2  0.389
2002 Raevskii KS, Gainetdinov RR, Budygin EA, Mannisto P, Wightman M. Dopaminergic transmission in the rat striatum in vivo in conditions of pharmacological modulation. Neuroscience and Behavioral Physiology. 32: 183-8. PMID 11942697 DOI: 10.1023/A:1013931609942  0.361
2001 Miller GW, Wang YM, Gainetdinov RR, Caron MG. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine. 62: 179-90. PMID 21318776 DOI: 10.1385/1-59259-142-6:179  0.318
2001 Gainetdinov RR, Mohn AR, Bohn LM, Caron MG. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 98: 11047-54. PMID 11572967 DOI: 10.1073/Pnas.191353298  0.418
2001 Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study) Pharmacological Research. 43: 283-290. PMID 11401421 DOI: 10.1006/phrs.2000.0773  0.353
2001 Budygin EA, Phillips PE, Robinson DL, Kennedy AP, Gainetdinov RR, Wightman RM. Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 27-34. PMID 11259524  0.317
2001 Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 1982-7. PMID 11172062 DOI: 10.1073/pnas.98.4.1982  0.398
2000 Walker JKL, Gainetdinov RR, Mangel AW, Caron MG, Shetzline MA. Mice lacking the dopamine transporter display altered regulation of distal colonic motility American Journal of Physiology - Gastrointestinal and Liver Physiology. 279: G311-G318. PMID 10915639  0.343
2000 Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience. 3: 465-71. PMID 10769386 DOI: 10.1038/74839  0.357
1999 Huotari M, Gainetdinov R, Männistö PT. Microdialysis studies on the action of tolcapone on pharmacologically- elevated extracellular dopamine levels in conscious rats Pharmacology and Toxicology. 85: 233-238. PMID 10608486 DOI: 10.1111/J.1600-0773.1999.Tb02014.X  0.42
1999 Jones SR, Gainetdinov RR, Caron MG. Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity. Psychopharmacology. 147: 30-2. PMID 10591864 DOI: 10.1007/s002130051137  0.318
1999 Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences. 20: 424-9. PMID 10498956 DOI: 10.1016/S0165-6147(99)01379-6  0.331
1999 Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biological Psychiatry. 46: 303-11. PMID 10435196 DOI: 10.1016/S0006-3223(99)00122-5  0.385
1999 Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nature Neuroscience. 2: 649-55. PMID 10404198 DOI: 10.1038/10204  0.395
1999 Budygin EA, Gainetdinov RR, Kilpatrick MR, Rayevsky KS, Männistö PT, Wightman RM. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. European Journal of Pharmacology. 370: 125-31. PMID 10323260 DOI: 10.1016/S0014-2999(99)00084-9  0.357
1999 Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2424-31. PMID 10087057 DOI: 10.1523/Jneurosci.19-07-02424.1999  0.365
1999 Melnikova V, Orosco M, Calas A, Sapronova A, Gainetdinov R, Delhaye-Bouchaud N, Nicolaidis S, Rayevsky K, Ugrumov M. Dopamine turnover in the mediobasal hypothalamus in rat fetuses. Neuroscience. 89: 235-41. PMID 10051232 DOI: 10.1016/S0306-4522(98)00278-4  0.399
1999 Gainetdinov RR. DOPAMINE AND NOREPINEPHRINE TRANSPORTER MUTANT MICE AND COCAINE DEPENDENCE Behavioural Pharmacology. 10: S36. DOI: 10.1097/00008877-199908001-00090  0.32
1999 Budygin EA, Kilpatrick M, Gainetdinov RR, Rayevsky KS, Wightman RM. The effect of the dopamine re-uptake inhibitor GBR 12909 on dopaminergic neurotransmission in rat striatum in vivo Eksperimental'Naya I Klinicheskaya Farmakologiya. 62: 5-6.  0.325
1998 Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381  0.31
1998 Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Research. Brain Research Reviews. 26: 148-53. PMID 9651511 DOI: 10.1016/S0165-0173(97)00063-5  0.364
1998 Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter Journal of Neuroscience. 18: 4861-4869. PMID 9634552  0.342
1998 Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Journal of Neurochemistry. 70: 1973-8. PMID 9572281 DOI: 10.1046/J.1471-4159.1998.70051973.X  0.313
1998 Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 95: 4029-34. PMID 9520487 DOI: 10.1073/Pnas.95.7.4029  0.385
1998 Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1979-86. PMID 9482784 DOI: 10.1523/Jneurosci.18-06-01979.1998  0.343
1998 Gainetdinov RR, Jones SR, Wightman RM, Carona MG. HYPERDOPAMINERGIC PHENOTYPE OF DOPAMINE TRANSPORTER KNOCKOUT MICE Behavioural Pharmacology. 9: S39. DOI: 10.1097/00008877-199808000-00075  0.353
1998 Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. Erratum: Cocaine self-administration in dopamine-transporter knockout mice Nature Neuroscience. 1: 330-330. DOI: 10.1038/1152  0.371
1997 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo European Journal of Pharmacology. 340: 53-58. PMID 9527506 DOI: 10.1016/S0014-2999(97)01407-6  0.332
1997 Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19: 1285-96. PMID 9427251 DOI: 10.1016/S0896-6273(00)80419-5  0.371
1997 Gainetdinov RR, Fumagalli F, Jones SR, Caron MG. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. Journal of Neurochemistry. 69: 1322-5. PMID 9282960 DOI: 10.1046/J.1471-4159.1997.69031322.X  0.347
1997 Bossé R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19: 127-38. PMID 9247269 DOI: 10.1016/S0896-6273(00)80353-0  0.325
1997 Rayevsky K, Kudrin V, Ganiev M, Gainetdinov R, Sotnikova T. P.2.086 Typical and atypical antipsychotics differ by their relation to various subtypes of brain dopamine receptor European Neuropsychopharmacology. 7: S219. DOI: 10.1016/S0924-977X(97)88720-2  0.329
1997 Rayevsky K, Sotnikova T, Gainetdinov R. Atypical antipsychotics affect prefferentially dopamine but not dopac extracellular levels in rat dorsal striatum Biological Psychiatry. 42: 174S. DOI: 10.1016/S0006-3223(97)87614-7  0.316
1997 Budygin EA, Gainetdinov RR, Raevsky KS, Li IH, Mannisto PT. Microdialysis of the effect of tolcapone in GBR-12909-induced blockade of dopamine uptake Eksperimental'Naya I Klinicheskaya Farmakologiya. 60: 10.  0.333
1997 Rayevsky KS, Gainetdinov RR, Sotnikova TD. Functional heterogeneity of brain dopamine recetors and effects of old and new antipsychotics Faseb Journal. 11: A212.  0.317
1996 Raevskii KS, Sotnikova TD, Gainetdinov RR. The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation | Dofaminergicheskie sistemy mozga: retseptornaia geterogennost', funktsional'naia rol', farmakologicheskaia reguliatsiia Uspekhi Fiziologicheskikh Nauk. 27: 3-29. PMID 9019922  0.329
1996 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis European Journal of Pharmacology. 308: 261-269. PMID 8858296 DOI: 10.1016/0014-2999(96)00300-7  0.343
1996 Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors subtype D3 predominantly regulate the liberation of dopamine in rat brain basal ganglia | Dofaminovye autoretseptory D3 podtipa preimushchestvenno reguliruiut vysvobozhdenie dofamina v bazal'nykh gangliiakh mozga krys Biulleten' Eksperimental'Noi Biologii I Meditsiny. 121: 430-434. PMID 8829459  0.31
1996 Gainetdinov RR, Raevskii KS. Substances increasing the extracellular content of dopamine in the striatum prevent the development of haloperidol catalepsy in rats Bulletin of Experimental Biology and Medicine. 121: 399-401.  0.31
1996 Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors of subtype D3 regulate mainly dopamine release in the basal ganglia of rat brain Bulletin of Experimental Biology and Medicine. 121: 392-396.  0.34
1995 Rayevsky KS, Gainetdinov RR, Grekhova TV, Sotnikova TD. Regulation of dopamine release and metabolism in rat striatum in vivo: Effects of dopamine receptor antagonists Progress in Neuropsychopharmacology and Biological Psychiatry. 19: 1285-1303. PMID 8868210 DOI: 10.1016/0278-5846(95)00267-7  0.332
1995 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Preferential role of D3 dopamine autoreceptor in regulation of dopamine release but not synthesis in nucleus accumbens and dorsal striatum of freely moving rats Behavioural Pharmacology. 6: 74. DOI: 10.1097/00008877-199505001-00088  0.318
1994 Gainetdinov RR, Grekhova TV, Sotnikova TD, Rayevsky KS. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats European Journal of Pharmacology. 261: 327-331. PMID 7813556 DOI: 10.1016/0014-2999(94)90125-2  0.345
Low-probability matches (unlikely to be authored by this person)
1995 Gainetdinov R, Sotnikova T, Grekhova T, Rayevsky K. Erratum to “estimation of the interstitial free concentration of the putative dopamine D3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats” [Neurosci. Lett. 193 (1995) 65–67] Neuroscience Letters. 199: 234. DOI: 10.1016/0304-3940(95)12093-J  0.298
1996 Gainetdinov RR, Raevskii KS. Substances that increase the extracellular level of dopamine in the striatum prevent development of haloperidol catalepsy in rats | Veshchestva, povyshaiushchie ékstrakletochnoe soderzhanie dofamina v striatum, prepiatstvuiut razvitiiu galoperiodolvoi katalepsii u krys Biulleten' Eksperimental'Noi Biologii I Meditsiny. 121: 438-440. PMID 8829461  0.297
2003 Phillips PE, Johns JM, Lubin DA, Budygin EA, Gainetdinov RR, Lieberman JA, Wightman RM. Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine. Brain Research. 961: 63-72. PMID 12535777 DOI: 10.1016/S0006-8993(02)03840-4  0.297
2019 Aleksandrov AA, Knyazeva VM, Volnova AB, Dmitrieva ES, Polyakova NV, Gainetdinov RR. Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice. Frontiers in Pharmacology. 10: 470. PMID 31130864 DOI: 10.3389/fphar.2019.00470  0.297
2018 Leo D, Sukhanov I, Gainetdinov RR. Novel translational rat models of dopamine transporter deficiency. Neural Regeneration Research. 13: 2091-2093. PMID 30323131 DOI: 10.4103/1673-5374.241453  0.296
2019 Adinolfi A, Zelli S, Leo D, Carbone C, Mus L, Illiano P, Alleva E, Gainetdinov RR, Adriani W. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system. Behavioural Brain Research. 359: 516-527. PMID 30472113 DOI: 10.1016/J.Bbr.2018.11.028  0.295
2000 Budygin EA, Kilpatrick MR, Gainetdinov RR, Wightman RM. Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry. Neuroscience Letters. 281: 9-12. PMID 10686403 DOI: 10.1016/S0304-3940(00)00813-2  0.294
2011 Guzman MS, De Jaeger X, Raulic S, Souza IA, Li AX, Schmid S, Menon RS, Gainetdinov RR, Caron MG, Bartha R, Prado VF, Prado MA. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. Plos Biology. 9: e1001194. PMID 22087075 DOI: 10.1371/Journal.Pbio.1001194  0.294
2015 Espinoza S, Lignani G, Caffino L, Maggi S, Sukhanov I, Leo D, Mus L, Emanuele M, Ronzitti G, Harmeier A, Medrihan L, Sotnikova TD, Chieregatti E, Hoener MC, Benfenati F, ... ... Gainetdinov RR, et al. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2217-27. PMID 25749299 DOI: 10.1038/Npp.2015.65  0.294
2020 Sanna F, Bratzu J, Serra MP, Leo D, Quartu M, Boi M, Espinoza S, Gainetdinov RR, Melis MR, Argiolas A. Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study. Frontiers in Behavioral Neuroscience. 14: 58. PMID 32372926 DOI: 10.3389/fnbeh.2020.00058  0.293
1995 Pletnicov MV, Storozheva ZL, Gainetdinov RR, Sotnikava TD, Rayevsky KS. D3 dopamine receptor and development of anxiety in rats Behavioural Pharmacology. 6: 37. DOI: 10.1097/00008877-199505001-00043  0.292
1992 Gainetdinov RR, Gromov AI, Kudrin VS, Pletnikov MS. Effect of haloperidol on extracellular concentrations of dopamine and its metabolites in the rat septum during muricidal aggression Bulletin of Experimental Biology and Medicine. 114: 1221-1223. DOI: 10.1007/BF00809539  0.291
2004 Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. Journal of Neurochemistry. 91: 362-73. PMID 15447669 DOI: 10.1111/j.1471-4159.2004.02721.x  0.291
1997 Budygin EA, Gainetdinov RR, Titov DA, Kovalev GI. Effect of the aspartic acid derivatives N-acetyl-aspartate and its phosphonic analog PIR-87-6-0 on the release of dopamine from rat striatum during in vitro perfusion Bulletin of Experimental Biology and Medicine. 123: 49-51. DOI: 10.1007/Bf02764377  0.29
2015 Cotter R, Pei Y, Mus L, Harmeier A, Gainetdinov RR, Hoener MC, Canales JJ. The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects. Frontiers in Neuroscience. 9: 39. PMID 25762894 DOI: 10.3389/Fnins.2015.00039  0.289
2007 Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biological Psychiatry. 61: 65-9. PMID 16712807 DOI: 10.1016/J.Biopsych.2006.03.020  0.287
2014 Leo D, Sukhanov I, Illiano P, Mus L, Espinoza S, Sotdnikova T, Hoener M, Gainetdinov R. P.1.g.030 Pronounced dopaminergic dysregulation in dopamine transporter knockout rats European Neuropsychopharmacology. 24: S220-S221. DOI: 10.1016/S0924-977X(14)70341-4  0.286
2009 Xu TX, Sotnikova TD, Liang C, Zhang J, Jung JU, Spealman RD, Gainetdinov RR, Yao WD. Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14086-99. PMID 19906957 DOI: 10.1523/Jneurosci.0974-09.2009  0.286
2008 Ramsey AJ, Laakso A, Cyr M, Sotnikova TD, Salahpour A, Medvedev IO, Dykstra LA, Gainetdinov RR, Caron MG. Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2701-14. PMID 18185498 DOI: 10.1038/Sj.Npp.1301663  0.285
2018 Mikhailova MA, Deal A, Grinevich VP, Bonin KD, Gainetdinov RR, Budygin EA. Real-time accumbal dopamine response to negative stimuli: Effects of ethanol. Acs Chemical Neuroscience. PMID 30289684 DOI: 10.1021/acschemneuro.8b00272  0.285
1998 Budygin EA, Gainetdinov RR, Raevskii KS, Mannisto PT. Effect of subchronic administration of tolcapone on L-DOPA- and carbidopa-induced release of striatal dopamine and its metabolites Bulletin of Experimental Biology and Medicine. 125: 145-147. DOI: 10.1007/Bf02496843  0.282
1991 Bogdanov MB, Gainetdinov RR, Kudrin VS, Medvedev OS, Val'dman AV. Microdialysis study of effects of atypical neuroleptics and anxiolytics on striatal dopamine release and metabolism in conscious rats Bulletin of Experimental Biology and Medicine. 111: 655-658. DOI: 10.1007/BF00841009  0.282
2012 Espinoza S, Manago F, Leo D, Sotnikova TD, Gainetdinov RR. Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson's disease and L-DOPA treatment. Cns & Neurological Disorders Drug Targets. 11: 251-63. PMID 22483291  0.281
2013 Espinoza S, Masri B, Salahpour A, Gainetdinov RR. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling. Methods in Molecular Biology (Clifton, N.J.). 964: 107-22. PMID 23296781 DOI: 10.1007/978-1-62703-251-3_8  0.281
2014 Gainetdinov R. S.04.02 Molecular modulation of dopamine transmission by TAAR1 European Neuropsychopharmacology. 24: S114-S115. DOI: 10.1016/S0924-977X(14)70133-6  0.279
2012 Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velázquez-Sánchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, et al. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biological Psychiatry. 72: 934-42. PMID 22705041 DOI: 10.1016/J.Biopsych.2012.05.014  0.277
2002 Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology. 175: 35-48. PMID 12009758 DOI: 10.1006/Exnr.2002.7882  0.277
2001 Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 15312-7. PMID 11752469 DOI: 10.1073/pnas.261583798  0.276
2022 Krasavin M, Peshkov AA, Lukin A, Komarova K, Vinogradova L, Smirnova D, Kanov EV, Kuvarzin SR, Murtazina RZ, Efimova EV, Gureev M, Onokhin K, Zakharov K, Gainetdinov RR. Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)--(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders. International Journal of Molecular Sciences. 23. PMID 36232878 DOI: 10.3390/ijms231911579  0.276
2003 Gainetdinov RR, Caron MG. Monoamine transporters: from genes to behavior. Annual Review of Pharmacology and Toxicology. 43: 261-84. PMID 12359863 DOI: 10.1146/annurev.pharmtox.43.050802.112309  0.275
2003 Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10265-73. PMID 14614085  0.274
1999 Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science (New York, N.Y.). 283: 397-401. PMID 9888856 DOI: 10.1126/Science.283.5400.397  0.273
1996 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Simultaneous monitoring of dopamine, its metabolites and trans-isomer of atypical neuroleptic drug carbidine concentrations in striatal dialysates of conscious rats Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20: 291-305. PMID 8861194 DOI: 10.1016/0278-5846(95)00311-8  0.273
2023 Kalinina DS, Lyakhovetskii VA, Gorskii OV, Shkorbatova PY, Pavlova NV, Bazhenova EY, Sysoev YI, Gainetdinov RR, Musienko PE. Alteration of Postural Reactions in Rats with Different Levels of Dopamine Depletion. Biomedicines. 11. PMID 37509596 DOI: 10.3390/biomedicines11071958  0.273
2016 Gainetdinov R. Functional consequences of modulating dopamine and glutamate transmission by TAAR1 Intrinsic Activity. 4: A3.4. DOI: 10.25006/IA.4.S2-A3.4  0.272
2022 Ptukha M, Fesenko Z, Belskaya A, Gromova A, Pelevin A, Kurzina N, Gainetdinov RR, Volnova A. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats. Biomolecules. 12. PMID 36291693 DOI: 10.3390/biom12101484  0.271
1999 Gainetdinov RR, Bohn LM, Walker JK, Laporte SA, Macrae AD, Caron MG, Lefkowitz RJ, Premont RT. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron. 24: 1029-36. PMID 10624964 DOI: 10.1016/S0896-6273(00)81048-X  0.271
1999 Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell. 98: 427-436. PMID 10481908 DOI: 10.1016/S0092-8674(00)81972-8  0.271
2009 Sotnikova TD, Caron MG, Gainetdinov RR. Trace amine-associated receptors as emerging therapeutic targets. Molecular Pharmacology. 76: 229-35. PMID 19389919 DOI: 10.1124/mol.109.055970  0.269
2004 Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annual Review of Neuroscience. 27: 107-44. PMID 15217328 DOI: 10.1146/Annurev.Neuro.27.070203.144206  0.269
2004 Yao WD, Gainetdinov RR, Arbuckle MI, Sotnikova TD, Cyr M, Beaulieu JM, Torres GE, Grant SG, Caron MG. Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron. 41: 625-38. PMID 14980210 DOI: 10.1016/S0896-6273(04)00048-0  0.268
2019 Aleksandrov AA, Polyakova NV, Vinogradova EP, Gainetdinov RR, Knyazeva VM. The TAAR5 agonist α-NETA causes dyskinesia in mice. Neuroscience Letters. PMID 30986441 DOI: 10.1016/j.neulet.2019.04.028  0.267
1995 Grekhova TV, Gainetdinov RR, Sotnikova TD, Krasnykh LM, Kudrin VS, Sergeeva SA, Morozov IS. Effect of bromantane, a new immunostimulating agent with psychostimulating activity, on the release and metabolism of dopamine in the striatum of freely moving rats. A microdialysis study Bulletin of Experimental Biology and Medicine. 119: 294-296. DOI: 10.1007/BF02445840  0.266
2010 Caron MG, Gainetdinov RR. Role of Dopamine Transporters in Neuronal Homeostasis Dopamine Handbook. DOI: 10.1093/acprof:oso/9780195373035.003.0007  0.265
2019 Beaulieu J, Borrelli E, Carlsson A, Caron MG, Civelli O, Espinoza S, Fisone G, Gainetdinov RR, Grandy DK, Kebabian JW, Langer SZ, Missale MC, Neve KA, Scatton B, Schwartz J, et al. Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f20/2019.4  0.264
2022 Vaganova AN, Katolikova NV, Murtazina RZ, Kuvarzin SR, Gainetdinov RR. Public Transcriptomic Data Meta-Analysis Demonstrates TAAR6 Expression in the Mental Disorder-Related Brain Areas in Human and Mouse Brain. Biomolecules. 12. PMID 36139098 DOI: 10.3390/biom12091259  0.264
2018 Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion On Therapeutic Targets. PMID 29798691 DOI: 10.1080/14728222.2018.1480723  0.263
2022 Zhukov IS, Ptukha MA, Zolotoverkhaja EA, Sinitca EL, Tissen IY, Karpova IV, Volnova AB, Gainetdinov RR. Evaluation of Approach to a Conspecific and Blood Biochemical Parameters in TAAR1 Knockout Mice. Brain Sciences. 12. PMID 35625001 DOI: 10.3390/brainsci12050614  0.262
2005 Medvedev IO, Gainetdinov RR, Sotnikova TD, Bohn LM, Caron MG, Dykstra LA. Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. Psychopharmacology. 180: 408-13. PMID 15719221 DOI: 10.1007/S00213-005-2173-Y  0.261
1995 Gainetdinov R, Sotnikova T, Grekhova T, Rayevsky K. Effects of typical and atypical neuroleptics on dopamine release and metabolism in rat striatumin vivo: Systemic and local administration Pharmacological Research. 31: 284. DOI: 10.1016/1043-6618(95)87397-X  0.26
2022 Kurzina N, Belskaya A, Gromova A, Ignashchenkova A, Gainetdinov RR, Volnova A. Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats α2A-Adrenoceptors. Frontiers in Psychiatry. 13: 851296. PMID 35401264 DOI: 10.3389/fpsyt.2022.851296  0.26
2000 Caron MG, Mohn AR, Gainetdinov RR. Manifestation of dopamine and glutamate systems dysfunction in animal models of schizoid behavior Acta Neurologica Scandinavica, Supplement. 102: 14-15.  0.258
2021 Illiano P, Leo D, Gainetdinov RR, Pardo M. Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter. Biomedicines. 9. PMID 33562738 DOI: 10.3390/biomedicines9020157  0.257
2019 Leo D, Espinoza S, Villers A, Gainetdinov R, Ris L. Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in Alzheimer disease Frontiers in Neuroscience. 13. DOI: 10.3389/Conf.Fnins.2019.96.00055  0.257
2009 Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annual Review of Pharmacology and Toxicology. 49: 327-47. PMID 18928402 DOI: 10.1146/annurev.pharmtox.011008.145634  0.256
2006 Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, Amaral E, Ramsey AJ, Sotnikova TD, Ramirez MR, Kim HG, Rossato JI, Koenen J, Quan H, Cota VR, Moraes MF, ... ... Gainetdinov RR, et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron. 51: 601-12. PMID 16950158 DOI: 10.1016/J.Neuron.2006.08.005  0.254
2023 Cichero E, Francesconi V, Casini B, Casale M, Kanov E, Gerasimov AS, Sukhanov I, Savchenko A, Espinoza S, Gainetdinov RR, Tonelli M. Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays. Pharmaceuticals (Basel, Switzerland). 16. PMID 38004497 DOI: 10.3390/ph16111632  0.254
2002 Gainetdinov RR, Sotnikova TD, Caron MG. Monoamine transporter pharmacology and mutant mice. Trends in Pharmacological Sciences. 23: 367-73. PMID 12377578 DOI: 10.1016/S0165-6147(02)02044-8  0.254
2009 Dzirasa K, Ramsey AJ, Takahashi DY, Stapleton J, Potes JM, Williams JK, Gainetdinov RR, Sameshima K, Caron MG, Nicolelis MA. Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8215-24. PMID 19553461 DOI: 10.1523/Jneurosci.1773-09.2009  0.254
1992 Gainetdinov RR, Budygin EA, Kovalev GI, Kudrin VS, Raevskii KS. Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum Bulletin of Experimental Biology and Medicine. 114: 971-974. DOI: 10.1007/BF00790057  0.253
2010 Dzirasa K, Phillips HW, Sotnikova TD, Salahpour A, Kumar S, Gainetdinov RR, Caron MG, Nicolelis MA. Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6387-97. PMID 20445065 DOI: 10.1523/Jneurosci.0764-10.2010  0.253
2014 Sukhanov I, Placido I, Leo D, Sotnikova T, Hoener M, Gainetdinov R. P.1.h.027 Dopamine transporter knockout rats: new experimental model in behavioral psychopharmacology research European Neuropsychopharmacology. 24: S285. DOI: 10.1016/S0924-977X(14)70450-X  0.253
2009 Dzirasa K, Santos LM, Ribeiro S, Stapleton J, Gainetdinov RR, Caron MG, Nicolelis MA. Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleep. Plos One. 4: e5238. PMID 19381303 DOI: 10.1371/Journal.Pone.0005238  0.25
1995 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Estimation of the interstitial free concentration of the putative dopamine D3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats Neuroscience Letters. 193: 65-67. PMID 7566669 DOI: 10.1016/0304-3940(95)11653-E  0.248
1995 Salimov RM, Poletaeva II, Kovalev GI, Salimova NB, Gainetdinov RR. Interstrain differences in extrapolation capacity and exploration of a cruciform maze correlate with various indices of monoamine metabolism in the brain | Mezhlineinye razlichia v sposobnosti k ékstrapoliatsii i v osvoenii krestoobraznogo labirinta korreliruiut s raznymi pokazateliami obmena monoaminov mozga Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova. 45: 914-924. PMID 8560938  0.248
2019 Apryatin SA, Shipelin VA, Trusov NV, Mzhelskaya KV, Evstratova VS, Kirbaeva NV, Soto JS, Fesenko ZS, Gainetdinov RR, Gmoshinski IV. Comparative analysis of the influence of a high-fat/high-carbohydrate diet on the level of anxiety and neuromotor and cognitive functions in Wistar and DAT-KO rats. Physiological Reports. 7: e13987. PMID 30784211 DOI: 10.14814/phy2.13987  0.248
2023 Kuvarzin SR, Sukhanov I, Onokhin K, Zakharov K, Gainetdinov RR. Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders. Biomedicines. 11. PMID 37509616 DOI: 10.3390/biomedicines11071977  0.247
2001 Gainetdinov RR, Mohn AR, Caron MG. Genetic animal models: Focus on schizophrenia Trends in Neurosciences. 24: 527-533. PMID 11506886 DOI: 10.1016/S0166-2236(00)01886-5  0.246
2013 Espinoza S, Sukhanov I, Lignani G, Medrihan L, Maggi S, Giannotti G, Fumagalli F, Benfenati F, Tucci V, Gainetdinov R. S.07.02 Role of trace amine-associated receptor 1 (TAAR1) in the modulation of dopaminergic system and cortico-striatal signalling European Neuropsychopharmacology. 23: S120. DOI: 10.1016/S0924-977X(13)70146-9  0.245
1995 Rayevsky K, Sotnikova T, Grekhova T, Gainetdinov R. Sydnocarb, An original psychostimulant, differs from amphetamine in respect to brain dopaminergic transmission: Behavioral and microdialysis study in rats Pharmacological Research. 31: 30. DOI: 10.1016/1043-6618(95)86378-8  0.243
2022 Maggi S, Bon C, Gustincich S, Tucci V, Gainetdinov RR, Espinoza S. Improved cognitive performance in trace amine-associated receptor 5 (TAAR5) knock-out mice. Scientific Reports. 12: 14708. PMID 36038766 DOI: 10.1038/s41598-022-18924-z  0.243
2018 Sukhanov I, Dorotenko A, Dolgorukova A, Hoener MC, Gainetdinov RR, Bespalov AY. Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats. Neuropharmacology. 144: 184-192. PMID 30366004 DOI: 10.1016/j.neuropharm.2018.10.034  0.243
2014 Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein. The Journal of Biological Chemistry. 289: 11715-24. PMID 24619418 DOI: 10.1074/Jbc.M113.544312  0.242
2022 Krasavin M, Lukin A, Sukhanov I, Gerasimov AS, Kuvarzin S, Efimova EV, Dorofeikova M, Nichugovskaya A, Matveev A, Onokhin K, Zakharov K, Gureev M, Gainetdinov RR. Discovery of Trace Amine Associated Receptor 1 (TAAR1) Agonist 2-(5-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders. Biomolecules. 12. PMID 36359001 DOI: 10.3390/biom12111650  0.241
2017 Bespalov M, Cherepkova M, Pörsti E, Abdurakhmanova S, Gainetdinov R, Piepponen P, Otonkoski T. Cerebral Organoids for Modelling Human Brain Development and Drugs Activity Mechanisms of Development. 145: S161-S162. DOI: 10.1016/J.Mod.2017.04.462  0.24
2020 Espinoza S, Sukhanov I, Efimova EV, Kozlova A, Antonova KA, Illiano P, Leo D, Merkulyeva N, Kalinina D, Musienko P, Rocchi A, Mus L, Sotnikova TD, Gainetdinov RR. Trace Amine-Associated Receptor 5 Provides Olfactory Input Into Limbic Brain Areas and Modulates Emotional Behaviors and Serotonin Transmission. Frontiers in Molecular Neuroscience. 13: 18. PMID 32194374 DOI: 10.3389/Fnmol.2020.00018  0.24
2018 Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors. Pharmacological Reviews. 70: 549-620. PMID 29941461 DOI: 10.1124/pr.117.015305  0.24
2013 Sotnikova TD, Espinoza S, Gainetdinov RR. Trace Amines and Their Receptors: New Opportunities for Modulation of Brain Dopaminergic Functions Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 92-93. DOI: 10.1016/B978-0-12-800044-1.00079-9  0.239
2003 Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 100: 8987-92. PMID 12851457 DOI: 10.1073/Pnas.1432926100  0.238
2022 Grinevich VP, Zakirov AN, Berseneva UV, Gerasimova EV, Gainetdinov RR, Budygin EA. Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders. Cells. 11. PMID 35563838 DOI: 10.3390/cells11091533  0.235
2010 Gainetdinov RR. Strengths and limitations of genetic models of ADHD. Attention Deficit and Hyperactivity Disorders. 2: 21-30. PMID 21432587 DOI: 10.1007/s12402-010-0021-3  0.235
2008 de Araujo IE, Oliveira-Maia AJ, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. Food reward in the absence of taste receptor signaling. Neuron. 57: 930-41. PMID 18367093 DOI: 10.1016/j.neuron.2008.01.032  0.234
2018 Sukhanov I, Dorofeikova M, Dolgorukova A, Dorotenko A, Gainetdinov RR. Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine. Frontiers in Pharmacology. 9: 329. PMID 29681856 DOI: 10.3389/fphar.2018.00329  0.233
2019 Aleksandrov AA, Dmitrieva ES, Volnova AB, Knyazeva VM, Gainetdinov RR, Polyakova NV. Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice. Neuroreport. PMID 31503202 DOI: 10.1097/WNR.0000000000001313  0.232
2015 Chiellini G, Nesi G, Digiacomo M, Malvasi R, Espinoza S, Sabatini M, Frascarelli S, Laurino A, Cichero E, Macchia M, Gainetdinov RR, Fossa P, Raimondi L, Zucchi R, Rapposelli S. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists. Journal of Medicinal Chemistry. 58: 5096-107. PMID 26010728 DOI: 10.1021/Acs.Jmedchem.5B00526  0.23
2004 Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (New York, N.Y.). 305: 217. PMID 15247473 DOI: 10.1126/science.1097540  0.23
2016 Illiano P, Lanzo A, Leo D, Paglione M, Zampi G, Gainetdinov RR, Schiavi ED. A Caenorhabditis elegans model to study Dopamine Transporter Deficiency Syndrome. The European Journal of Neuroscience. PMID 27519790 DOI: 10.1111/ejn.13366  0.23
1993 Budygin EA, Kovalev GI, Gainetdinov RR, Kudrin VS, Voronina TA. Age-related changes in the dopaminergic system of rat striatum Bulletin of Experimental Biology and Medicine. 115: 331-333. DOI: 10.1007/BF00836430  0.23
1999 Wang YM, Xu F, Gainetdinov RR, Caron MG. Genetic approaches to studying norepinephrine function: Knockout of the mouse norepinephrine transporter gene Biological Psychiatry. 46: 1124-1130. PMID 10560019 DOI: 10.1016/S0006-3223(99)00245-0  0.229
2014 Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ. Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2299-308. PMID 24722355 DOI: 10.1038/Npp.2014.88  0.228
2022 Zhukov IS, Vaganova AN, Murtazina RZ, Alferova LS, Ermolenko EI, Gainetdinov RR. Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats. Biomolecules. 12. PMID 36551251 DOI: 10.3390/biom12121823  0.228
2022 Pardo M, Martin M, Gainetdinov RR, Mash DC, Izenwasser S. Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females. International Journal of Molecular Sciences. 23. PMID 36499749 DOI: 10.3390/ijms232315414  0.228
2023 Veshchitskii A, Shkorbatova P, Mikhalkin A, Fesenko Z, Efimova EV, Gainetdinov RR, Merkulyeva N. Activation of the spinal and brainstem locomotor networks during free treadmill stepping in rats lacking dopamine transporter. Frontiers in Molecular Neuroscience. 16: 1299297. PMID 38076209 DOI: 10.3389/fnmol.2023.1299297  0.226
2016 Cichero E, Espinoza S, Tonelli M, Franchini S, Gerasimov AS, Sorbi C, Gainetdinov RR, Brasili L, Fossa P. A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists Medchemcomm. 7: 353-364. DOI: 10.1039/c5md00490j  0.224
2004 Walker JK, Gainetdinov RR, Feldman DS, McFawn PK, Caron MG, Lefkowitz RJ, Premont RT, Fisher JT. G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation. American Journal of Physiology. Lung Cellular and Molecular Physiology. 286: L312-9. PMID 14565944 DOI: 10.1152/Ajplung.00255.2003  0.223
1996 Budygin EA, Gainetdinov RR, Titov DA, Kovalev GI. The low-dose effect of pyracetam on the activity of the dopaminergic system of the striatum in the brain of rats Eksperimental'Naya I Klinicheskaya Farmakologiya. 59: 8.  0.222
2011 Omenetti A, Yang L, Gainetdinov RR, Guy CD, Choi SS, Chen W, Caron MG, Diehl AM. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. American Journal of Physiology. Gastrointestinal and Liver Physiology. 300: G303-15. PMID 21071507 DOI: 10.1152/Ajpgi.00368.2010  0.222
2023 Vilca S, Wahlestedt C, Izenwasser S, Gainetdinov RR, Pardo M. Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure. Biomolecules. 13. PMID 37509143 DOI: 10.3390/biom13071107  0.222
2005 Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. The Journal of Biological Chemistry. 280: 12774-80. PMID 15687500 DOI: 10.1074/jbc.M408901200  0.221
2000 Bohn LM, Xu F, Gainetdinov RR, Caron MG. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9040-5. PMID 11124980 DOI: 10.1523/Jneurosci.20-24-09040.2000  0.22
2008 Vinuela A, Hallett PJ, Reske-Nielsen C, Patterson M, Sotnikova TD, Caron MG, Gainetdinov RR, Isacson O. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Brain : a Journal of Neurology. 131: 3361-79. PMID 18988638 DOI: 10.1093/brain/awn192  0.219
2006 Dzirasa K, Ribeiro S, Costa R, Santos LM, Lin SC, Grosmark A, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA. Dopaminergic control of sleep-wake states. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10577-89. PMID 17035544 DOI: 10.1523/Jneurosci.1767-06.2006  0.219
2013 Cichero E, Espinoza S, Gainetdinov RR, Brasili L, Fossa P. Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies. Chemical Biology & Drug Design. 81: 509-16. PMID 22883051 DOI: 10.1111/cbdd.12018  0.218
2022 Bon C, Chern TR, Cichero E, O'Brien TE, Gustincich S, Gainetdinov RR, Espinoza S. Discovery of Novel Trace Amine-Associated Receptor 5 (TAAR5) Antagonists Using a Deep Convolutional Neural Network. International Journal of Molecular Sciences. 23. PMID 35328548 DOI: 10.3390/ijms23063127  0.217
2018 Adinolfi A, Carbone C, Leo D, Gainetdinov RR, Laviola G, Adriani W. Novelty-related behavior of young and adult DAT-KO rats: implication for cognitive and emotional phenotypic patterns. Genes, Brain, and Behavior. PMID 29406596 DOI: 10.1111/gbb.12463  0.217
2021 Lopachev AV, Lagarkova MA, Lebedeva OS, Ezhova MA, Kazanskaya RB, Timoshina YA, Khutorova AV, Akkuratov EE, Fedorova TN, Gainetdinov RR. Ouabain-Induced Gene Expression Changes in Human iPSC-Derived Neuron Culture Expressing Dopamine and cAMP-Regulated Phosphoprotein 32 and GABA Receptors. Brain Sciences. 11. PMID 33562186 DOI: 10.3390/brainsci11020203  0.217
1993 Kovalev GI, Budygin EA, Gainetdinov RR, Kudrin VS, Trofimov SS, Ostrovskaya RU. Use of sodium hydroxybutyrate and nooglutyl to correct dopamine release in the striatum of prenatally alcoholized rat pups Bulletin of Experimental Biology and Medicine. 116: 832-834. DOI: 10.1007/BF00786165  0.216
2013 Leo D, Gainetdinov RR. Transgenic mouse models for ADHD. Cell and Tissue Research. 354: 259-71. PMID 23681253 DOI: 10.1007/s00441-013-1639-1  0.216
2021 Vaganova AN, Murtazina RZ, Shemyakova TS, Prjibelski AD, Katolikova NV, Gainetdinov RR. Pattern of TAAR5 Expression in the Human Brain Based on Transcriptome Datasets Analysis. International Journal of Molecular Sciences. 22. PMID 34445502 DOI: 10.3390/ijms22168802  0.216
2019 Dorofeikova M, Gerasimov A, Lukin A, Sukhanov I, Krasavin M, Gainetdinov R. Identification of a novel trace amine-associated receptor 1 agonist with in vivo activity European Neuropsychopharmacology. 29: S190. DOI: 10.1016/j.euroneuro.2018.11.320  0.215
2016 Sukhanov I, Sotnikova T, Gainetdinov R. Differences in effects of NMDA receptor antagonists in BARR2-KO mice European Neuropsychopharmacology. 26: S276. DOI: 10.1016/S0924-977X(16)31163-4  0.215
2018 Kostrzewa RM, Wydra K, Filip M, Crawford C, McDougall SA, Brown RW, Borroto-Escuela DO, Fuxe K, Gainetdinov RR. Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders. The Journal of Pharmacology and Experimental Therapeutics. PMID 29921706 DOI: 10.1124/Jpet.118.247981  0.214
2021 Kurzina NP, Volnova AB, Aristova IY, Gainetdinov RR. A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition. Frontiers in Behavioral Neuroscience. 15: 654469. PMID 33967714 DOI: 10.3389/fnbeh.2021.654469  0.212
2012 Sukhanov I, Espinoza S, Yakovlev D, Hoener M, Sotnikova T, Gainetdinov R. P.1.d.014 Altered effects of apomorphine in TAAR1 knockout mice European Neuropsychopharmacology. 22: S189. DOI: 10.1016/S0924-977X(12)70272-9  0.212
2015 Urs NM, Bido S, Peterson SM, Daigle TL, Bass CE, Gainetdinov RR, Bezard E, Caron MG. Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 112: E2517-26. PMID 25918399 DOI: 10.1073/Pnas.1502740112  0.212
2009 Raehal KM, Schmid CL, Medvedev IO, Gainetdinov RR, Premont RT, Bohn LM. Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6. Drug and Alcohol Dependence. 104: 187-96. PMID 19497686 DOI: 10.1016/J.Drugalcdep.2009.04.011  0.212
2013 Theka I, Caiazzo M, Dvoretskova E, Leo D, Ungaro F, Curreli S, Managò F, Dell'Anno MT, Pezzoli G, Gainetdinov RR, Dityatev A, Broccoli V. Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. Stem Cells Translational Medicine. 2: 473-9. PMID 23658252 DOI: 10.5966/sctm.2012-0133  0.211
2019 Dorotenko A, Tur M, Dolgorukova A, Bortnikov N, Belozertseva IV, Zvartau EE, Gainetdinov RR, Sukhanov I. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats. Cellular and Molecular Neurobiology. PMID 31734895 DOI: 10.1007/s10571-019-00757-6  0.211
2017 Bono F, Savoia P, Guglielmi A, Gennarelli M, Piovani G, Sigala S, Leo D, Espinoza S, Gainetdinov RR, Devoto P, Spano P, Missale C, Fiorentini C. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons. Molecular Neurobiology. PMID 28092083 DOI: 10.1007/s12035-016-0376-3  0.21
2022 Leo D, Targa G, Espinoza S, Villers A, Gainetdinov RR, Ris L. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease. International Journal of Molecular Sciences. 23. PMID 35887159 DOI: 10.3390/ijms23147811  0.21
2022 Katolikova NV, Vaganova AN, Efimova EV, Gainetdinov RR. Expression of Trace Amine-Associated Receptors in the Murine and Human Hippocampus Based on Public Transcriptomic Data. Cells. 11. PMID 35681508 DOI: 10.3390/cells11111813  0.209
2014 Cichero E, Espinoza S, Franchini S, Guariento S, Brasili L, Gainetdinov RR, Fossa P. Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach. Chemical Biology & Drug Design. 84: 712-20. PMID 24894156 DOI: 10.1111/cbdd.12367  0.206
2023 Nicoli A, Weber V, Bon C, Steuer A, Gustincich S, Gainetdinov RR, Lang R, Espinoza S, Di Pizio A. Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists. Journal of Chemical Information and Modeling. 63: 6667-6680. PMID 37847527 DOI: 10.1021/acs.jcim.3c00755  0.205
2011 Caiazzo M, Dell'Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G, Russo G, Carninci P, Pezzoli G, Gainetdinov RR, Gustincich S, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 476: 224-7. PMID 21725324 DOI: 10.1038/Nature10284  0.202
2021 Grinevich VP, Krupitsky EM, Gainetdinov RR, Budygin EA. Linking Ethanol-Addictive Behaviors With Brain Catecholamines: Release Pattern Matters. Frontiers in Behavioral Neuroscience. 15: 795030. PMID 34975429 DOI: 10.3389/fnbeh.2021.795030  0.2
2019 Zhukov IS, Kubarskaya LG, Tissen IY, Kozlova AA, Dagayev SG, Kashuro VA, Vlasova OL, Sinitca EL, Karpova IV, Gainetdinov RR. Minimal Age-Related Alterations in Behavioral and Hematological Parameters in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice. Cellular and Molecular Neurobiology. 40: 273-282. PMID 31399838 DOI: 10.1007/s10571-019-00721-4  0.199
2012 Salahpour A, Espinoza S, Masri B, Lam V, Barak LS, Gainetdinov RR. BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Frontiers in Endocrinology. 3: 105. PMID 22952466 DOI: 10.3389/Fendo.2012.00105  0.198
2002 Laakso A, Mohn AR, Gainetdinov RR, Caron MG. Experimental genetic approaches to addiction. Neuron. 36: 213-28. PMID 12383778 DOI: 10.1016/S0896-6273(02)00972-8  0.198
2008 Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proceedings of the National Academy of Sciences of the United States of America. 105: 13656-61. PMID 18768802 DOI: 10.1073/Pnas.0803522105  0.198
2016 Tonelli M, Espinoza S, Gainetdinov RR, Cichero E. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies. European Journal of Medicinal Chemistry. PMID 27823885 DOI: 10.1016/j.ejmech.2016.10.058  0.198
2004 Bohn LM, Gainetdinov RR, Caron MG. G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. Neuromolecular Medicine. 5: 41-50. PMID 15001811 DOI: 10.1385/Nmm:5:1:041  0.197
2020 Serikuly N, Alpyshov ET, Wang D, Wang J, Yang L, Hu G, Yan D, Demin KA, Kolesnikova TO, Galstyan D, Amstislavskaya TG, Babashev AM, Mor MS, Efimova EV, Gainetdinov RR, et al. Effects of acute and chronic arecoline in adult zebrafish: Anxiolytic-like activity, elevated brain monoamines and the potential role of microglia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109977. PMID 32454162 DOI: 10.1016/j.pnpbp.2020.109977  0.197
2007 Premont RT, Gainetdinov RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Annual Review of Physiology. 69: 511-34. PMID 17305472 DOI: 10.1146/Annurev.Physiol.69.022405.154731  0.196
2001 Premont RT, Gainetdinov RR, Caron MG. Following the trace of elusive amines Proceedings of the National Academy of Sciences of the United States of America. 98: 9474-9475. PMID 11504935 DOI: 10.1073/Pnas.181356198  0.196
2023 Katolikova NV, Vaganova AN, Shafranskaya DD, Efimova EV, Malashicheva AB, Gainetdinov RR. Expression Pattern of Trace Amine-Associated Receptors during Differentiation of Human Pluripotent Stem Cells to Dopaminergic Neurons. International Journal of Molecular Sciences. 24. PMID 37894992 DOI: 10.3390/ijms242015313  0.195
2017 Berry MD, Gainetdinov RR, Hoener MC, Shahid M. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Pharmacology & Therapeutics. PMID 28723415 DOI: 10.1016/j.pharmthera.2017.07.002  0.195
2018 Deal AL, Mikhailova MA, Grinevich VP, Weiner JL, Gainetdinov RR, Budygin EA. In vivo voltammetric evidence that locus coeruleus activation predominantly releases norepinephrine in the infralimbic cortex: Effect of acute ethanol. Synapse (New York, N.Y.). PMID 30447016 DOI: 10.1002/Syn.22080  0.195
2023 Vaganova AN, Maslennikova DD, Konstantinova VV, Kanov EV, Gainetdinov RR. The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand-Receptor Systems and Depends on Tumor Intrinsic Subtype. Biomolecules. 13. PMID 37759760 DOI: 10.3390/biom13091361  0.194
2023 Vaganova AN, Shemyakova TS, Lenskaia KV, Rodionov RN, Steenblock C, Gainetdinov RR. Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets. Biomolecules. 13. PMID 38002300 DOI: 10.3390/biom13111618  0.194
1995 Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS. Effect of original psychostimulant drug sydnocarb on brain dopaminergic transmission Behavioural Pharmacology. 6: 28. DOI: 10.1097/00008877-199505001-00030  0.194
2020 Belov DR, Fesenko ZS, Lakstygal AM, Gainetdinov RR, Kolodyazhnyi SF. Effects of a Trace Amine-Associated Receptor TAAR5 Agonist as a Model of Schizophrenia Using Electrocorticography Data from Rats Neuroscience and Behavioral Physiology. 50: 335-344. DOI: 10.1007/s11055-020-00905-2  0.192
2020 Illiano P, Bigford GE, Gainetdinov RR, Pardo M. Rats Lacking Dopamine Transporter Display Increased Vulnerability and Aberrant Autonomic Response to Acute Stress. Biomolecules. 10. PMID 32486390 DOI: 10.3390/biom10060842  0.191
2017 Dolgorukova A, Dorotenko A, Mus L, Gainetdinov R, Sukhanov I. Activation of trace amine-associated receptor 1 reduces schedule-induced polydipsia in rats European Neuropsychopharmacology. 27: S673. DOI: 10.1016/S0924-977X(17)31254-3  0.182
2010 Sotnikova TD, Gainetdinov RR. Octopamine and Other Monoamines in Invertebrates Encyclopedia of Neuroscience. 9-15. DOI: 10.1016/B978-008045046-9.01158-X  0.181
2021 Murtazina RZ, Zhukov IS, Korenkova OM, Popova EA, Kuvarzin SR, Efimova EV, Kubarskaya LG, Batotsyrenova EG, Zolotoverkhaya EA, Vaganova AN, Apryatin SA, Alenina NV, Gainetdinov RR. Genetic Deletion of Trace-Amine Associated Receptor 9 (TAAR9) in Rats Leads to Decreased Blood Cholesterol Levels. International Journal of Molecular Sciences. 22. PMID 33799339 DOI: 10.3390/ijms22062942  0.181
2016 Chiellini G, Nesi G, Sestito S, Chiarugi S, Runfola M, Espinoza S, Sabatini M, Bellusci L, Laurino A, Cichero E, Gainetdinov RR, Fossa P, Raimondi L, Zucchi R, Rapposelli S. Hit-to-lead optimization of mouse Trace Amine Associated Receptor 1 (mTAAR1) agonists with a diphenylmethane-scaffold: Design, Synthesis, and biological study. Journal of Medicinal Chemistry. PMID 27731647 DOI: 10.1021/Acs.Jmedchem.6B01092  0.18
2008 Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, Gainetdinov RR, Caron MG. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America. 105: 1333-8. PMID 18212115 DOI: 10.1073/Pnas.0711496105  0.177
2007 Gainetdinov RR. Mesolimbic dopamine in obesity and diabetes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 293: R601-2. PMID 17596319 DOI: 10.1152/ajpregu.00450.2007  0.177
2013 Espinoza S, Sukhanov I, Lignani G, Medrihan L, Maggi S, Giannotti G, Fumagalli F, Benfenati F, Tucci V, Gainetdinov R. P.1.022 Role of trace amine-associated receptor 1 (TAAR1) in the modulation of the dopaminergic system and cortico-striatal signalling European Neuropsychopharmacology. 23: S21-S22. DOI: 10.1016/S0924-977X(13)70024-5  0.176
2014 Ronzitti G, Bucci G, Emanuele M, Leo D, Sotnikova TD, Mus LV, Soubrane CH, Dallas ML, Thalhammer A, Cingolani LA, Mochida S, Gainetdinov RR, Stephens GJ, Chieregatti E. Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 10603-15. PMID 25100594 DOI: 10.1523/Jneurosci.0608-14.2014  0.174
2011 Herrmann R, Heflin SJ, Hammond T, Lee B, Wang J, Gainetdinov RR, Caron MG, Eggers ED, Frishman LJ, McCall MA, Arshavsky VY. Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. Neuron. 72: 101-10. PMID 21982372 DOI: 10.1016/J.Neuron.2011.07.030  0.172
2008 Barak LS, Salahpour A, Zhang X, Masri B, Sotnikova TD, Ramsey AJ, Violin JD, Lefkowitz RJ, Caron MG, Gainetdinov RR. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Molecular Pharmacology. 74: 585-94. PMID 18524885 DOI: 10.1124/Mol.108.048884  0.171
2023 Markina AA, Kazanskaya RB, Timoshina JA, Zavialov VA, Abaimov DA, Volnova AB, Fedorova TN, Gainetdinov RR, Lopachev AV. Na,K-ATPase and Cardiotonic Steroids in Models of Dopaminergic System Pathologies. Biomedicines. 11. PMID 37509460 DOI: 10.3390/biomedicines11071820  0.17
2020 Francesconi V, Cichero E, Kanov EV, Laurini E, Pricl S, Gainetdinov RR, Tonelli M. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals (Basel, Switzerland). 13. PMID 33202687 DOI: 10.3390/ph13110391  0.169
2017 Bazhenova EY, Sinyakova NA, Kulikova EA, Kazarinova IA, Bazovkina DV, Gainetdinov RR, Kulikov AV. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice. Neuroscience Letters. PMID 28579486 DOI: 10.1016/j.neulet.2017.05.070  0.167
2006 Zhang X, Beaulieu JM, Gainetdinov RR, Caron MG. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cellular and Molecular Life Sciences : Cmls. 63: 6-11. PMID 16378243 DOI: 10.1007/s00018-005-5417-4  0.167
1999 Gainetdinov RR, Caron MG. Delineating muscarinic receptor functions Proceedings of the National Academy of Sciences of the United States of America. 96: 12222-12223. PMID 10535900 DOI: 10.1073/pnas.96.22.12222  0.165
2017 Aleksandrov AA, Dmitrieva ES, Volnova AB, Knyazeva VM, Gerasimov AS, Gainetdinov RR. TAAR5 receptor agonist affects sensory gating in rats. Neuroscience Letters. 666: 144-147. PMID 29288046 DOI: 10.1016/j.neulet.2017.12.053  0.165
2022 Vaganova AN, Kuvarzin SR, Sycheva AM, Gainetdinov RR. Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma. Biomolecules. 12. PMID 35053262 DOI: 10.3390/biom12010114  0.163
2016 Mus L, Espinoza S, Ronzitti G, Mingozzi F, Gainetdinov R. Peripheral immunization of mice to produce antibodies against NMDA receptor as a potential approach to create a rodent model of schizophrenia European Neuropsychopharmacology. 26: S271-S272. DOI: 10.1016/S0924-977X(16)31156-7  0.161
2023 Katolikova NV, Khudiakov AA, Shafranskaya DD, Prjibelski AD, Masharskiy AE, Mor MS, Golovkin AS, Zaytseva AK, Neganova IE, Efimova EV, Gainetdinov RR, Malashicheva AB. Modulation of Notch Signaling at Early Stages of Differentiation of Human Induced Pluripotent Stem Cells to Dopaminergic Neurons. International Journal of Molecular Sciences. 24. PMID 36674941 DOI: 10.3390/ijms24021429  0.16
2021 Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, ... ... Gainetdinov RR, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. British Journal of Pharmacology. 178: S27-S156. PMID 34529832 DOI: 10.1111/bph.15538  0.158
2010 Siesser WB, Zhang X, Jacobsen JP, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice. Neuroscience Letters. 481: 6-11. PMID 20600620 DOI: 10.1016/j.neulet.2010.06.035  0.158
2015 Gurevich EV, Premont RT, Gainetdinov RR. G protein-coupled receptor kinases: from molecules to diseases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 361-4. PMID 25649814 DOI: 10.1096/Fj.14-263657Ufm  0.158
2018 Aleksandrov AA, Knyazeva VM, Volnova AB, Dmitrieva ES, Korenkova O, Espinoza S, Gerasimov A, Gainetdinov RR. Identification of TAAR5 Agonist Activity of Alpha-NETA and Its Effect on Mismatch Negativity Amplitude in Awake Rats. Neurotoxicity Research. PMID 29713997 DOI: 10.1007/s12640-018-9902-6  0.157
2010 Sotnikova TD, Beaulieu J, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator Plos One. 5. DOI: 10.1371/Annotation/A2019934-B1Cc-4781-80Cb-9E09Fc7Ff6Dc  0.157
2023 Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, ... ... Gainetdinov RR, et al. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. British Journal of Pharmacology. S23-S144. PMID 38123151 DOI: 10.1111/bph.16177  0.154
2009 de Castro BM, Pereira GS, Magalhães V, Rossato JI, De Jaeger X, Martins-Silva C, Leles B, Lima P, Gomez MV, Gainetdinov RR, Caron MG, Izquierdo I, Cammarota M, Prado VF, Prado MA. Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes, Brain, and Behavior. 8: 23-35. PMID 18778400 DOI: 10.1111/J.1601-183X.2008.00439.X  0.154
2008 de Araujo IE, Oliveira-Maia AJ, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis ML, Simon SA. Food Reward in the Absence of Taste Receptor Signaling (DOI:10.1016/j.neuron.2008.01.032) Neuron. 58: 295. DOI: 10.1016/j.neuron.2008.04.003  0.15
2008 Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, Wetsel WC, Lefkowitz RJ, Gainetdinov RR, Caron MG. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell. 132: 125-36. PMID 18191226 DOI: 10.1016/J.Cell.2007.11.041  0.147
1999 Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science (New York, N.Y.). 286: 2495-8. PMID 10617462 DOI: 10.1126/Science.286.5449.2495  0.147
2019 Aleksandrov AA, Dmitrieva ES, Volnova AB, Knyazeva VM, Polyakova NV, Ptukha MA, Gainetdinov RR. Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice. Neuroscience Letters. 712: 134470. PMID 31476355 DOI: 10.1016/j.neulet.2019.134470  0.144
2013 Siesser WB, Sachs BD, Ramsey AJ, Sotnikova TD, Beaulieu JM, Zhang X, Caron MG, Gainetdinov RR. Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice. Acs Chemical Neuroscience. 4: 84-8. PMID 23336047 DOI: 10.1021/cn300127h  0.143
2017 Sukhanov I, Dorotenko A, Dolgorukova A, Dorofeikova M, Gainetdinov R. The trace amine-associated receptor 1 modulates nicotine behavioural effects European Neuropsychopharmacology. 27: S673-S674. DOI: 10.1016/S0924-977X(17)31255-5  0.143
2000 Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 408: 720-3. PMID 11130073 DOI: 10.1038/35047086  0.142
1993 Grekhova TV, Romanova GA, Gainetdinov RR, Kudrin VS, Raevskii KS. Effects of N-acetylaspartic acid on the brain after frontal lobectomy in rats: Antiamnestic effect and influence on monoamine content Bulletin of Experimental Biology and Medicine. 115: 155-158. DOI: 10.1007/BF00847180  0.139
2014 Dell'Anno MT, Caiazzo M, Leo D, Dvoretskova E, Medrihan L, Colasante G, Giannelli S, Theka I, Russo G, Mus L, Pezzoli G, Gainetdinov RR, Benfenati F, Taverna S, Dityatev A, et al. Remote control of induced dopaminergic neurons in parkinsonian rats. The Journal of Clinical Investigation. 124: 3215-29. PMID 24937431 DOI: 10.1172/Jci74664  0.139
2020 Levchenko A, Kanapin A, Samsonova A, Fedorenko OY, Kornetova EG, Nurgaliev T, Mazo GE, Semke AV, Kibitov AO, Bokhan NA, Gainetdinov RR, Ivanova SA. A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 105: 110134. PMID 33065217 DOI: 10.1016/j.pnpbp.2020.110134  0.137
2018 Guariento S, Tonelli M, Espinoza S, Gerasimov AS, Gainetdinov RR, Cichero E. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists. European Journal of Medicinal Chemistry. 146: 171-184. PMID 29407948 DOI: 10.1016/j.ejmech.2018.01.059  0.137
2020 Demin KA, Lakstygal AM, Krotova NA, Masharsky A, Tagawa N, Chernysh MV, Ilyin NP, Taranov AS, Galstyan DS, Derzhavina KA, Levchenko NA, Kolesnikova TO, Mor MS, Vasyutina ML, Efimova EV, ... ... Gainetdinov RR, et al. Understanding complex dynamics of behavioral, neurochemical and transcriptomic changes induced by prolonged chronic unpredictable stress in zebrafish. Scientific Reports. 10: 19981. PMID 33203921 DOI: 10.1038/s41598-020-75855-3  0.136
2000 Gainetdinov RR, Premont RT, Caron MG, Lefkowitz RJ. Reply: receptor specificity of G-protein-coupled receptor kinases Trends in Pharmacological Sciences. 21: 366-7. PMID 11050311 DOI: 10.1016/S0165-6147(00)01538-8  0.134
2018 Kulikov AV, Gainetdinov RR, Ponimaskin E, Kalueff AV, Naumenko VS, Popova NK. Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy. Expert Opinion On Therapeutic Targets. PMID 29542343 DOI: 10.1080/14728222.2018.1452912  0.132
2011 Zhang X, Nicholls PJ, Laje G, Sotnikova TD, Gainetdinov RR, Albert PR, Rajkowska G, Stockmeier CA, Speer MC, Steffens DC, Austin MC, McMahon FJ, Krishnan KR, Garcia-Blanco MA, Caron MG. A functional alternative splicing mutation in human tryptophan hydroxylase-2. Molecular Psychiatry. 16: 1169-76. PMID 20856248 DOI: 10.1097/01.Yic.0000405901.80483.0B  0.131
2016 Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, Miranda HC, Lievens PM, Espinoza S, Jochum T, Rocchi A, Grunseich C, Gainetdinov RR, Cato AC, Lieberman AP, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Science Translational Medicine. 8: 370ra181. PMID 28003546 DOI: 10.1126/scitranslmed.aaf9526  0.128
2019 Sukhanov I, Dorotenko A, Bortnikov N, Tur M, Dolgorukova A, Dorofeikova M, Belozertseva I, Gainetdinov R. Evaluation of effects of the TAAR1 partial agonist RO5263397 on executive cognitive functions European Neuropsychopharmacology. 29: S261-S262. DOI: 10.1016/j.euroneuro.2018.11.417  0.127
2021 Kozlova AA, Ragavan VN, Jarzebska N, Lukianova IV, Bikmurzina AE, Rubets E, Suzuki-Yamamoto T, Kimoto M, Mangoni AA, Gainetdinov RR, Weiss N, Bauer M, Markov AG, Rodionov RN, Bernhardt N. Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System. Cellular and Molecular Neurobiology. PMID 34014421 DOI: 10.1007/s10571-021-01101-7  0.127
2015 Colasante G, Lignani G, Rubio A, Medrihan L, Yekhlef L, Sessa A, Massimino L, Giannelli SG, Sacchetti S, Caiazzo M, Leo D, Alexopoulou D, Dell'Anno MT, Ciabatti E, Orlando M, ... ... Gainetdinov RR, et al. Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming. Cell Stem Cell. PMID 26526726 DOI: 10.1016/J.Stem.2015.09.002  0.126
2017 Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. Psychedelic Drugs in Biomedicine. Trends in Pharmacological Sciences. PMID 28947075 DOI: 10.1016/j.tips.2017.08.003  0.125
2020 Kazanskaya RB, Lopachev AV, Fedorova TN, Gainetdinov RR, Volnova AB. A low-cost and customizable alternative for commercial implantable cannula for intracerebral administration in mice. Hardwarex. 8: e00120. PMID 35498269 DOI: 10.1016/j.ohx.2020.e00120  0.124
2016 Homberg JR, Kyzar EJ, Nguyen M, Norton WH, Pittman J, Poudel MK, Gaikwad S, Nakamura S, Koshiba M, Yamanouchi H, Scattoni ML, Ullman JF, Diamond DM, Kaluyeva AA, Parker MO, ... ... Gainetdinov RR, et al. Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models. Neuroscience and Biobehavioral Reviews. PMID 27048961 DOI: 10.1016/J.Neubiorev.2016.03.013  0.122
2021 Glyakina AV, Pavlov CD, Sopova JV, Gainetdinov RR, Leonova EI, Galzitskaya OV. Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors. International Journal of Molecular Sciences. 23. PMID 35008636 DOI: 10.3390/ijms23010209  0.12
2001 Gainetdinov RR, Caron MG, Lombroso PJ. Genetics of childhood disorders: XXIV. ADHD, part 8: Hyperdopaminergic mice as an animal model of ADHD Journal of the American Academy of Child and Adolescent Psychiatry. 40: 380-382. PMID 11288782  0.117
2017 Maggi S, Balzani E, Lassi G, Garcia-Garcia C, Plano A, Espinoza S, Mus L, Tinarelli F, Nolan PM, Gainetdinov RR, Balci F, Nieus T, Tucci V. The after-hours circadian mutant has reduced phenotypic plasticity in behaviors at multiple timescales and in sleep homeostasis. Scientific Reports. 7: 17765. PMID 29259298 DOI: 10.1038/S41598-017-18130-2  0.114
2006 Caron M, Zhang X, Beaulieu J, Gainetdinov R, Sotnikova T. S.28.02 Influence of variants of TPH2 on the regulation of the central serotonin system European Neuropsychopharmacology. 16: S203-S204. DOI: 10.1016/S0924-977X(06)70130-4  0.114
2020 Demin KA, Lakstygal AM, Chernysh MV, Krotova NA, Taranov AS, Ilyin NP, Seredinskaya MV, Tagawa N, Savva AK, Mor MS, Vasyutina ML, Efimova EV, Kolesnikova TO, Gainetdinov RR, Strekalova T, et al. The zebrafish tail immobilization (ZTI) test as a new tool to assess stress-related behavior and a potential screen for drugs affecting despair-like states. Journal of Neuroscience Methods. 108637. PMID 32081675 DOI: 10.1016/j.jneumeth.2020.108637  0.108
2016 Homberg JR, Kyzar EJ, Scattoni ML, Norton WH, Pittman J, Gaikwad S, Nguyen M, Poudel MK, Ullmann JF, Diamond DM, Kaluyeva AA, Parker MO, Brown RE, Song C, Gainetdinov RR, et al. Genetic and environmental modulation of neurodevelopmental disorders: translational insights from labs to beds. Brain Research Bulletin. PMID 27113433 DOI: 10.1016/J.Brainresbull.2016.04.015  0.107
2017 Levchenko A, Kanapin A, Samsonova A, Gainetdinov R. Human accelerated regions and other human-specific sequence variations in the context of evolution and their relevance for brain development. Genome Biology and Evolution. PMID 29149249 DOI: 10.1093/gbe/evx240  0.106
2022 Kozlova AA, Vaganova AN, Rodionov RN, Gainetdinov RR, Bernhardt N. Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods. International Journal of Molecular Sciences. 23. PMID 36233204 DOI: 10.3390/ijms231911902  0.105
2022 Efimova EV, Katolikova NV, Kanov EV, Gainetdinov RR. Trace amine-associated receptors at the cross-road between innate olfaction of amines, emotions, and adult neurogenesis. Neural Regeneration Research. 17: 1257-1258. PMID 34782562 DOI: 10.4103/1673-5374.327338  0.101
1991 Osnyach VS, Kudrin VS, Gainetdinov RR, Sergeev PV. Action of small doses of irradiation on hypothalamic monoamine levels in hypoxic and normoxic rats Bulletin of Experimental Biology and Medicine. 112: 1508-1510. DOI: 10.1007/BF00841386  0.1
2000 Logman MJ, Budygin EA, Gainetdinov RR, Wightman RM. Quantitation of in vivo measurements with carbon fiber microelectrodes. Journal of Neuroscience Methods. 95: 95-102. PMID 10752479 DOI: 10.1016/S0165-0270(99)00155-7  0.094
2005 Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KR, Caron MG. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 45: 11-6. PMID 15629698 DOI: 10.1016/J.Neuron.2004.12.014  0.093
2006 Sotnikova TD, Gainetdinov RR. Chapter 5.1 Microdialysis in genetically altered animals Handbook of Behavioral Neuroscience. 16: 399-417. DOI: 10.1016/S1569-7339(06)16021-X  0.092
1995 KOVALEV G, GAINETDINOV R, SALIMOV R, ZHARIKOV S, TIMOFEYEV A. Modulation of neurotransmission is a common neurochemical property of cognitive enhancers Pharmacological Research. 31: 263-263. DOI: 10.1016/1043-6618(95)87310-4  0.092
2008 Murphy KL, Zhang X, Gainetdinov RR, Beaulieu JM, Caron MG. A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression. The Journal of Biological Chemistry. 283: 13216-24. PMID 18339632 DOI: 10.1074/Jbc.M706749200  0.092
1992 Gainetdinov RR, Bogdanov MB, Kudrin VS, Budygin EA, Kovalev GI, Raevskii KS. Comparison of neurochemical activity profiles of remoxipride, raclopride, and metoclopramide Bulletin of Experimental Biology and Medicine. 114: 1135-1139. DOI: 10.1007/BF00800074  0.091
2014 Espinoza S, Lignani G, Sukhanov I, Caffino L, Maggi S, Leo D, Tucci V, Fumagalli F, Gainetdinov R. P.1.j.018 TAAR1 deficiency produces frontostriatal dysfunctions European Neuropsychopharmacology. 24: S329-S330. DOI: 10.1016/S0924-977X(14)70523-1  0.085
2000 Gainetdinov RR, Caron MG. An animal model of attention deficit hyperactivity disorder Molecular Medicine Today. 6: 43-44. PMID 10637574 DOI: 10.1016/S1357-4310(99)01616-0  0.079
2021 Bornstein SR, Voit-Bak K, Donate T, Rodionov RN, Gainetdinov RR, Tselmin S, Kanczkowski W, Müller GM, Achleitner M, Wang J, Licinio J, Bauer M, Young AH, Thuret S, Bechmann N, et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Molecular Psychiatry. PMID 34140635 DOI: 10.1038/s41380-021-01148-4  0.078
2003 Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nature Reviews. Neuroscience. 4: 13-25. PMID 12511858 DOI: 10.1038/nrn1008  0.078
2000 Sarkis EH, Gainetdinov RR, Wetsel WC, Caron MG. 'Model' behavior [4] (multiple letters) Science. 287: 2160-2162. PMID 10744536  0.077
2020 Levchenko A, Nurgaliev T, Kanapin A, Samsonova A, Gainetdinov RR. Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders. Heliyon. 6: e03990. PMID 32462093 DOI: 10.1016/j.heliyon.2020.e03990  0.076
2013 Lignani G, Ferrea E, Difato F, Amarù J, Ferroni E, Lugarà E, Espinoza S, Gainetdinov RR, Baldelli P, Benfenati F. Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity. Frontiers in Molecular Neuroscience. 6: 22. PMID 23970852 DOI: 10.3389/Fnmol.2013.00022  0.07
2022 Bechmann N, Barthel A, Schedl A, Herzig S, Varga Z, Gebhard C, Mayr M, Hantel C, Beuschlein F, Wolfrum C, Perakakis N, Poston L, Andoniadou CL, Siow R, Gainetdinov RR, et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. The Lancet. Diabetes & Endocrinology. 10: 221-230. PMID 35114136 DOI: 10.1016/S2213-8587(21)00346-6  0.07
2018 Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Alekseeva PA, Meshalkina DA, Friend AJ, Bao W, Demin KA, Gainetdinov RR, Kalueff AV. Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models. European Journal of Pharmacology. PMID 29627310 DOI: 10.1016/j.ejphar.2018.04.003  0.069
2008 Caron M, Masri B, Beaulieu J, Salahpour A, Ramsey A, Sotnikova T, Gainetdinov R. S.20.03 β-Arrestin-dependent DAD2R/Akt/GSK3β signaling: relationship to mood stabilisers and antipsychotics European Neuropsychopharmacology. 18: S184. DOI: 10.1016/S0924-977X(08)70190-1  0.067
2022 Levchenko A, Malov S, Antonik A, Protsvetkina A, Rybakova KV, Kanapin A, Yakovlev AN, Nenasteva AY, Nikolishin AE, Cherkasov N, Chuprova NA, Blagonravova AS, Sergeeva AV, Zhilyaeva TV, Denisenko MK, ... Gainetdinov RR, et al. A Genome-Wide Association Study Reveals a -Centered Molecular Network Associated with Alcohol Dependence and Related Clinical Measures. Biomedicines. 10. PMID 36551763 DOI: 10.3390/biomedicines10123007  0.066
2008 Sharipov GL, Gainetdinov RK, Abdrakhmanov AM. Effect of argon on the multibubble sonoluminescence of cerium, terbium, and dysprosium trichlorides Russian Chemical Bulletin. 57: 1831-1836. DOI: 10.1007/s11172-008-0247-9  0.066
2005 Zhang X, Gainetdinov RR, Beaulieu J, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KRR, Caron MG. Response to Correspondence: Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression Neuron. 48: 705-706. DOI: 10.1016/J.Neuron.2005.11.021  0.065
2020 Leonova EI, Gainetdinov RR. CRISPR/Cas9 Technology in Translational Biomedicine. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 54: 354-370. PMID 32298553 DOI: 10.33594/000000224  0.06
1996 GAINETDINOV RR, SALIMOV RM, SALIMOV NB, SHVETS LN, KOVALEV GI. PINCH-INDUCED CATALEPSY AS A TOOL TO DETECT ANTIDEPRESSANT OR ANXIOLYTIC PROPERTIES Behavioural Pharmacology. 7: 39. DOI: 10.1097/00008877-199605001-00090  0.057
1999 Gainetdinov RR, Caron MG. Genetic models in pharmacology: Present status and future Pharmacological Research. 39: 403-404. PMID 10373248 DOI: 10.1006/phrs.1999.0498  0.057
2008 Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Wetsel WC, Gainetdinov RR, Caron MG. Reply to Belmaker et al.: GSK3β haploinsufficiency results in lithium-like effects in the forced-swim test Proceedings of the National Academy of Sciences of the United States of America. 105: E24. DOI: 10.1073/Pnas.0803026105  0.054
2021 Steenblock C, Richter S, Berger I, Barovic M, Schmid J, Schubert U, Jarzebska N, von Mässenhausen A, Linkermann A, Schürmann A, Pablik J, Dienemann T, Evert K, Rodionov RN, Semenova NY, ... ... Gainetdinov RR, et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nature Communications. 12: 3534. PMID 34112801 DOI: 10.1038/s41467-021-23886-3  0.052
2009 Omenetti A, Yang L, Gainetdinov RR, Choi SS, Witek RP, Jung Y, Syn W, Chen W, Caron MG, Diehl AM. 343 Myofibroblasts Promote the Growth of Biliary Tree During Cholestatic Liver Injury By Suppressing Tryptophan Hydroxylase 2 (TPH2) Expression and Serotonin Secretion in Neighboring Cholangiocytes Gastroenterology. 136: A-800. DOI: 10.1016/S0016-5085(09)63689-1  0.051
2021 Skorodumova LO, Belodedova AV, Sharova EI, Zakharova ES, Iulmetova LN, Bikbov MM, Usubov EL, Antonova OP, Selezneva OV, Levchenko A, Fedorenko OY, Ivanova SA, Gainetdinov RR, Malyugin BE. Rare single nucleotide variants in COL5A1 promoter do not play a major role in keratoconus susceptibility associated with rs1536482. Bmc Ophthalmology. 21: 357. PMID 34625056 DOI: 10.1186/s12886-021-02128-6  0.049
2019 Fedorenko OY, Golimbet VE, Ivanova SА, Levchenko А, Gainetdinov RR, Semke AV, Simutkin GG, Gareeva АE, Glotov АS, Gryaznova A, Iourov IY, Krupitsky EM, Lebedev IN, Mazo GE, Kaleda VG, et al. Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium. Molecular Psychiatry. PMID 30664668 DOI: 10.1038/s41380-019-0354-z  0.047
2005 Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, McGrath PJ, Rush J, Trivedi MH, Charney DS, Roy A, Wisniewski S, Lipsky R, Goldman D, Van Den Bogaert A, De Zutter S, ... ... Gainetdinov RR, et al. Response to Zhang et al. (2005) loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16 [2] (multiple letters) Neuron. 48: 702-706. PMID 16337901 DOI: 10.1016/J.Neuron.2005.11.018  0.042
2019 Katolikova N, Gainetdinov R. Primary neuronal culture as a source for direct reprogramming of the cells European Neuropsychopharmacology. 29: S584. DOI: 10.1016/j.euroneuro.2018.11.864  0.041
2017 Mikhailova M, Deal A, Budygin E, Gainetdinov R. Optogenetics: Applications in neurobiology Biological Communications. 62: 261-271. DOI: 10.21638/11701/spbu03.2017.405  0.032
2008 Ognev AN, Ryskal OE, Korotchenko AG, Gainetdinov RG. Using of C/O logging under low-porosity carbon bearing profiles conditions Saint Petersburg 2008: Geosciences - From New Ideas to New Discoveries 0.028
2005 Sharipov GL, Abdrakhmanov AM, Gainetdinov RK. On the emitters of sulfuric acid sonoluminescence Russian Chemical Bulletin. 54: 1793-1797. DOI: 10.1007/s11172-006-0038-0  0.023
2003 Sharipov GL, Abdrakhmanov AM, Gainetdinov RK. Sonoluminescence of aqueous solutions of sulfuric acid and sulfur dioxide Russian Chemical Bulletin. 52: 1966-1968. DOI: 10.1023/B:RUCB.0000009639.39650.14  0.017
2020 Steenblock C, Todorov V, Kanczkowski W, Eisenhofer G, Schedl A, Wong ML, Licinio J, Bauer M, Young AH, Gainetdinov RR, Bornstein SR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Molecular Psychiatry. PMID 32382135 DOI: 10.1038/S41380-020-0758-9  0.013
2012 Dragunov AA, Shaikhutdinov RS, Mukhamadiev RS, Gainetdinov R, Rakhimov R. Paleogeomorfologicheskie and fault-tectonic criteria for determining the types of traps for remote sites and geophysical Geobaikal 2012 - 2nd International Research and Application Conference On Electromagnetic Research Methods and Integrated Geophysical Data Interpretation 0.01
2010 Diyashev RN, Piyakov GN, Iksanov IM, Gainetdinov RF, Rahimov RL, Makatrov AK, Telin AG. Physical simulation of water alternation gas technology at the heavy oil carbonate reservoir conditions 4th International Conference and Exhibition: New Discoveries Through Integration of Geosciences, Saint Petersburg 2010 0.01
2008 Sharipov GL, Gainetdinov RK, Abdrakhmanov AM. Multibubble sonoluminescence of europium(III) chloride in heavy water Russian Chemical Bulletin. 57: 1827-1830. DOI: 10.1007/s11172-008-0246-x  0.01
2008 Perelygin VT, Mashkin AI, Ognev AN, Glukhov VL, Romanov VM, Gainetdinov RG. Modern apparatus and geophysical technologies for ore and hydrogeological wells survey Saint Petersburg 2008: Geosciences - From New Ideas to New Discoveries 0.01
2006 Sharipov GL, Gainetdinov RK, Abdrakhmanov AM. Sonoluminescence of terbium chloride in an H2O-D2O mixture Russian Chemical Bulletin. 55: 1114-1118. DOI: 10.1007/s11172-006-0386-9  0.01
2006 Bulgakov RG, Galimov DI, Ponomareva YG, Nevyadovskii EY, Gainetdinov RK. Quenching of electronically excited Ln3+* ions by C 60 fullerene Russian Chemical Bulletin. 55: 955-960. DOI: 10.1007/s11172-006-0361-5  0.01
2005 Sharipov GL, Gainetdinov RK, Abdrakhmanov AM. Sonoluminescence of aqueous solution of gadolinium chloride Russian Chemical Bulletin. 54: 1383-1386. DOI: 10.1007/s11172-005-0414-1  0.01
2003 Sharipov GL, Gainetdinov RK, Abdrakhmanov AM. Sonoluminescence of aqueous solutions of lanthanide salts Russian Chemical Bulletin. 52: 1969-1973. DOI: 10.1023/B:RUCB.0000009640.25570.49  0.01
Hide low-probability matches.